Mr
Rudolf
Erhardt Sachs

Senior European Patent Attorney

Munich Office

Engineering

Telephone. +49(0) 891 259 9600
Email. [email protected]

Experience

Rudolf started in 1996 working in the IP business. His experience and interests cover a wide field of technologies, allowing him to quickly understand a matter and pinpoint its issues in the field between technical, legal, and economic constraints.

Rudolf’s work approach is fact-oriented, diligent and analytical. He is dedicated to an in-depth understanding of any factors contributing to a case, giving best possible advice to clients and finding a solution that meets their needs.

Qualifications

Patent Attorney

European
German


DIPL.-ING

Mechanical Engineering / Aerospace Technology

OTHER

Diploma Mechanical Engineering

Publications

From March 1 Patronus IP have merged with HGF

View publication online

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

3D shape trade marks for medical devices

Innovation in medical devices continues strongly and the introduction of IoT and 3D printing (amongst others) has led to an acceleration in new medical devices. Whilst patents and designs are …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

“For medical purposes” – a case for unblurring the lines between pharma and nutritional products

Food-pharma industry convergence is not a new development. In 2013, a study of the patent citation data of 274 published European patents by 5 EU Medical Nutrition companies revealed the …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article
Event - 30th April 2022

INTA 2022 Annual Meeting Live+

The HGF European team will be attending the INTA 2022 Annual Meeting Live+. It is being held on 30th April – 4th May in Washington, D.C. INTA brings together the …

Event details

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.